255 related articles for article (PubMed ID: 30091683)
1. miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro.
Troschel FM; Böhly N; Borrmann K; Braun T; Schwickert A; Kiesel L; Eich HT; Götte M; Greve B
Tumour Biol; 2018 Aug; 40(8):1010428318791887. PubMed ID: 30091683
[TBL] [Abstract][Full Text] [Related]
2. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
Li Y; Wu C
IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
[TBL] [Abstract][Full Text] [Related]
3. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
[TBL] [Abstract][Full Text] [Related]
4. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
5. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
[TBL] [Abstract][Full Text] [Related]
6. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
Liu F; Liu Y; Shen J; Zhang G; Han J
Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
[TBL] [Abstract][Full Text] [Related]
9. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
12. [Influence factors on the formation of mammospheres from breast cancer stem cells].
Huang MZ; Zhang FC; Zhang YY
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):500-4. PubMed ID: 18931713
[TBL] [Abstract][Full Text] [Related]
13. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
Phillips TM; McBride WH; Pajonk F
J Natl Cancer Inst; 2006 Dec; 98(24):1777-85. PubMed ID: 17179479
[TBL] [Abstract][Full Text] [Related]
14. miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3β.
Song XL; Huang B; Zhou BW; Wang C; Liao ZW; Yu Y; Zhao SC
Biomed Pharmacother; 2018 Mar; 99():369-374. PubMed ID: 29358129
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation.
Zuo J; Yu Y; Zhu M; Jing W; Yu M; Chai H; Liang C; Tu J
Cancer Biomark; 2018 Feb; 21(2):383-392. PubMed ID: 29103027
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
17. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
[TBL] [Abstract][Full Text] [Related]
18. MiR-208a stimulates the cocktail of SOX2 and β-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a/let-7 feedback loop via LIN28 and DICER1.
Sun X; Jiang S; Liu J; Wang H; Zhang Y; Tang SC; Wang J; Du N; Xu C; Wang C; Qin S; Zhang J; Liu D; Zhang Y; Li X; Wang J; Dong J; Wang X; Xu S; Tao Z; Xu F; Zhou J; Wang T; Ren H
Oncotarget; 2015 Oct; 6(32):32944-54. PubMed ID: 26460550
[TBL] [Abstract][Full Text] [Related]
19. MiR-342-3p inhibits LCSC oncogenicity and cell stemness through HDAC7/PTEN axis.
Xu C; Sun W; Liu J; Pu H; Li Y
Inflamm Res; 2022 Jan; 71(1):107-117. PubMed ID: 34842937
[TBL] [Abstract][Full Text] [Related]
20. [Dendritic cells infected by recombinant adeno-associated virus with CEA gene to induce antigen-specific CTL response to CD44(+)CD24(-/low) cells from MCF-7 breast cancer cell line].
Wang XL; Ma B; Jia J; Yuan YH; Yan Y; Di LJ; Song GH; Yu J; Ren J
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):173-8. PubMed ID: 21503107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
